Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Neurology|August 26, 2021
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple SclerosisMarcus W Koch, Jop P Mostert, Jerry S Wolinsky, et al.
Neurology|April 21, 2025
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical TrialsLudwig Kappos, Sean Yiu, Frank Dahlke, et al.
Neurology|December 10, 2003
Effect of relapses on development of residual deficit in multiple sclerosisFred D Lublin, Monika Baier, Gary Cutter
Neurology|May 31, 2020
The 2013 clinical course descriptors for multiple sclerosis: A clarificationFred D Lublin, Timothy Coetzee, Jeffrey A Cohen, et al.
Neurology|February 15, 2015
Differences in Alzheimer disease clinical trial outcomes based on age of the participantsLon S Schneider, Richard E Kennedy, Guoqiao Wang, et al.
Neurology|August 11, 2021
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease SpectrumMarcus W Koch, Jop Mostert, Yinan Zhang, et al.
Neurology|April 8, 2025
Perspectives of People With Multiple Sclerosis Regarding Data Linkage and SharingRuth Ann Marrie, Mudita Sharma, Gary R Cutter, et al.
Neurology|December 23, 2024
Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple SclerosisAmber Salter, Samantha Lancia, Gary R Cutter, et al.
Neurology|February 22, 2013
Disability in multiple sclerosis: a reference for patients and cliniciansIlya Kister, Eric Chamot, Amber R Salter, et al.
Neurology|March 17, 2017
High hypothetical interest in physician-assisted death in multiple sclerosisRuth Ann Marrie, Amber Salter, Tuula Tyry, et al.
Pageof 3